Abstract
Over the past decade there has been substantial progress in understanding the molecular basis of several inherited cardiovascular disorders. Definition of the chromosome location of disease genes, identification of these genes, and characterization of different mutations within these disease genes has been the focus of many, molecular laboratories around the world. Translation of this new, fundamental genetic knowledge about human disorders, into improved clinical diagnosis and care of individuals affected by these disorders has become a new frontier in medicine. This translation is often hampered by a limited understanding by physicians of the difficulties of molecular genetic technologies and a failure by researchers to comprehend the complexities of clinical manifestations of disease. Despite these intrinsic problems, the effort of integrating basic science and medicine in hypertrophic cardiomyopathy has particular merit because the complex molecular genetics of this disease may account for the diverse clinical manifestations of this pathology. The paper will review our current understanding of the genetic basis for hypertrophie cardiomyopathy and discuss the impact this research has on clinical diagnosis and management.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG (1992) Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326:1108–1114
Watkins H, McKenna WJ, Thierfelder L, Suk J, Anan R, O’Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE (1995) The role of cardiac troponin T and α-tropomyosin mutations in hypertrophic cardiomyopathy. N Engl J Med 332:1058–1064
Niimura H, Bachinski LL, Watkins H, Thierfelder L, Chudley AE, Anastasakis A, Toutouzas P, Elstein E, Liew, C-C, Liew J, Rakowski H, Wigle ED, Zhao M, McKenna W, Sole M, Roberts R, Seidman JG, Seidman CE (1997) Human cardiac myosin binding protein C mutations cause late-onset familial hypertrophie cardiomyopathy; submitted.
Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND (1996) Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Genet 13:63–69
MacRae CA, Ghaisas N, Kass S, Donnelly S, Basson CT, Watkins H, Anan R, Theirfelder LH, McGarry K, Rowland E, McKenna W, Seidman, JG, Seidman CE (1995) Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 96:1216–1220
Solomon SD, Wolff S, Watkins H, Ridker PM, Come P, Seidman CE, McKenna WJ, Lee RT (1993) Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations in the β myosin heavy chain gene. J Am Coll Cardiol 22:498–505
Maron BJ, Lipson LC, Roberts WC, Savage DD, Epstein SE (1978) “Malignant ” hypertrophic cardiomyopathy: Identification of a subgroup of families with unusually frequent premature death. Am J Cardiol 41:1133–1139
Fananapazir L, Epstein ND (1994) Genotype-phenotype correlations in hypertrophie cardiomyopathy. Circulation 89:22–32
Anan R, Greve G, Thierfelder L, Watkins H, McKenna WJ, Solomon S, Vecchio C, Shono H, Nakao S, Tanaka H, Mares A, Towbin JA, Spirito P, Roberts R, Seidman JG, Seidman CE (1994) Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophie cardiomyopathy. J Clin Invest 93:280.
Coviello DA, Maron BJ, Spirito P (1996) Clinical features of hypertrophie cardiomyopathy caused by mutation of a “hot spot ” in the a tropomyosin gene. J Am Coll Cardiol 29:635–640
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Italia
About this paper
Cite this paper
Seidman, C. (1998). The Clinical Significance of Genetic Testing in Familial Hypertrophic Cardiomyopathy. In: Camerini, F., Gavazzi, A., De Maria, R. (eds) Advances in Cardiomyopathies. Springer, Milano. https://doi.org/10.1007/978-88-470-2155-6_3
Download citation
DOI: https://doi.org/10.1007/978-88-470-2155-6_3
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2181-5
Online ISBN: 978-88-470-2155-6
eBook Packages: Springer Book Archive